Blackfrog Technologies is a pioneering Indian med-tech company that specializes in precision cold-chain and medical refrigeration solutions for the healthcare sector. Founded in 2015 and headquartered in Manipal, Karnataka, the company designs and develops cutting-edge technologies that safeguard the transport and storage of temperature-sensitive biological products. Its flagship innovation, Emvólio, is a portable, battery-powered refrigeration device engineered for last-mile delivery of vaccines, blood samples, medicines, and other biologicals. The device maintains stringent temperature conditions even in the most remote and resource-constrained environments. By combining indigenous innovation with advanced engineering and adherence to WHO-compliant standards, Blackfrog Technologies is transforming healthcare logistics, minimizing vaccine wastage, and strengthening immunization outcomes across global markets. The company’s mission has attracted the backing of leading healthcare and impact-focused investors, further accelerating its growth and innovation journey.
In an exclusive interaction with The Interview World at the ASSOCHAM Pharma Summit & Awards 2026, Mayur Shetty, CEO of Blackfrog Technologies, discusses the company’s breakthrough innovations and examines the vast opportunities emerging in the last-mile delivery of temperature-sensitive pharmaceutical products. He also explains how technology-driven cold-chain solutions can significantly reduce wastage across the pharmaceutical supply chain while enhancing operational efficiency and product integrity. Furthermore, he shares insights into Blackfrog’s future innovation roadmap and the next generation of solutions the company is developing to address critical healthcare logistics challenges. Presented below are the key highlights from this insightful and thought-provoking conversation.
Q: What types of innovations have you introduced across the pharmaceutical supply chain, and what challenges were they designed to address?
A: At Blackfrog Technologies, we focus on bringing greater accountability, reliability, and intelligence to the medical cold chain, the critical infrastructure that underpins the pharmaceutical supply chain. To achieve this, we offer two distinct categories of solutions that address both transportation and monitoring challenges across the cold-chain ecosystem.
First, we provide portable, battery-powered refrigeration systems designed specifically for last-mile transportation of temperature-sensitive biological products. These solutions serve rural and remote regions where access to reliable electricity and conventional refrigeration infrastructure remains limited or entirely absent. Consequently, maintaining the integrity of vaccines, blood samples, medicines, and other biologicals becomes a significant challenge.
To bridge this gap, we developed Emvólio, a fully off-grid, backpack-mounted refrigeration system that enables healthcare workers to transport thermally sensitive products safely and efficiently, even in the most inaccessible locations. By ensuring uninterrupted temperature control during transit, Emvólio strengthens last-mile healthcare delivery and helps preserve the efficacy of life-saving medical products.
In addition, we offer advanced cold-chain monitoring solutions through our newly launched Emon Series. Powered by machine learning, these intelligent systems continuously monitor existing cold-chain infrastructure and deliver predictive maintenance capabilities. They oversee a wide range of assets, including refrigerated trucks, warehouses, large-scale refrigeration units, and walk-in cold rooms.
More importantly, the Emon platform detects temperature fluctuations, identifies operational anomalies, and evaluates equipment performance in real time. As a result, it can predict potential equipment failures before they occur. The system then alerts end users, operators, and healthcare workers, enabling them to take preventive action and avoid costly losses.
For example, if a facility stores blood bags, human organs, vaccines, or other high-value biological products, the system can provide early warnings of an impending refrigeration failure. This allows operators to relocate the inventory to a safe environment before any breakdown compromises product integrity.
Together, these solutions reflect Blackfrog Technologies’ commitment to building a smarter, more resilient, and more accountable medical cold chain, one that protects critical healthcare resources from the point of storage to the point of care.
Q: What opportunities do you see in last-mile delivery for perishable pharmaceutical products?
A: India has firmly established itself as a global pharmaceutical powerhouse. Today, the country produces a significant share of the world’s vaccines, and several of the world’s leading vaccine manufacturers operate from India. This strong foundation in research, development, and manufacturing has positioned the nation at the forefront of global healthcare innovation.
However, producing vaccines is only part of the equation. Once researchers develop effective vaccines and manufacturers scale production, a new challenge emerges: ensuring that these life-saving products reach their intended destinations safely and efficiently. Consequently, supply chain management becomes the critical link between innovation and impact.
The final bottleneck lies in transportation and distribution, particularly for temperature-sensitive vaccines and biological products. Without robust cold-chain infrastructure and reliable last-mile delivery mechanisms, even the most advanced medical products risk losing their efficacy before reaching patients.
This challenge presents a significant opportunity for India. As a leading pharmaceutical producer, the country is uniquely positioned to serve healthcare markets across the Global South. To realize this potential, however, India must complement its manufacturing excellence with world-class logistics and cold-chain capabilities.
That has been our focus at Blackfrog Technologies. Today, we manufacture and deploy solutions that support healthcare delivery across countries such as Kenya, Nigeria, Tanzania, and Fiji. Global development agencies procure many of these products to strengthen healthcare systems in regions where reliable cold-chain infrastructure remains a persistent challenge.
Going forward, India must elevate its capabilities in healthcare logistics and invest more aggressively in next-generation cold-chain technologies. By doing so, the country can not only reinforce its position as the pharmacy of the world but also emerge as a global leader in the safe, efficient, and equitable delivery of life-saving medicines and vaccines.
Q: How can technology help reduce waste across the pharmaceutical supply chain?
A: Absolutely. One of the primary causes of pharmaceutical wastage is cold-chain failure. In many cases, temperature-sensitive medicines, vaccines, and biological products leave manufacturing facilities in optimal condition. However, during transportation and storage, breaches in the cold chain can expose these products to temperatures outside their prescribed range. As a result, they lose potency before reaching the end beneficiary.
Importantly, this is not a failure of pharmaceutical science or manufacturing. Researchers develop highly effective medications, and manufacturers produce them to exacting quality standards. The real challenge arises further downstream, within the logistics and distribution ecosystem. Therefore, the issue is fundamentally a technological one.
In many respects, the problem stems from gaps in engineering, infrastructure, and process control rather than shortcomings in healthcare delivery or drug development. If the industry cannot maintain the required environmental conditions throughout the supply chain, even the most advanced therapies risk becoming ineffective by the time they reach patients.
At Blackfrog Technologies, we approach this challenge from a technology-first perspective. We believe innovation can significantly reduce cold-chain breaches and the resulting wastage. Accordingly, we develop solutions that enhance monitoring, improve traceability, and strengthen accountability across the movement and storage of temperature-sensitive biological products.
By integrating advanced refrigeration technologies, intelligent monitoring systems, and real-time data-driven insights, we enable stakeholders to maintain product integrity throughout the supply chain. Ultimately, better technology leads to greater accountability, lower wastage, and more reliable healthcare delivery, ensuring that life-saving medicines and vaccines reach patients with their efficacy fully intact.
Q: What other innovations or innovative products are you developing in this domain?
A: Today, we support the safe transport of a wide range of temperature-sensitive medical products, including vaccines, blood bags, and even corneal tissues used in transplantation procedures. However, our ambitions extend far beyond these applications. We are steadily moving up the healthcare value chain and expanding our capabilities to address more complex cold-chain requirements.
Accordingly, we are developing larger-capacity refrigeration systems designed for the storage and transportation of critical organs such as lungs, kidneys, and livers destined for transplantation. These high-value, life-saving biological assets demand uncompromising temperature control and end-to-end traceability. Consequently, ensuring accountability throughout the supply chain becomes not just important, but absolutely essential.
This represents a significant growth opportunity for Blackfrog Technologies and a key pillar of our long-term vision. Our goal is simple yet profound: to ensure that every temperature-sensitive medical product reaches the patient in the exact condition intended by its manufacturer.
Whether it is a vaccine administered to a newborn child, insulin delivered to a patient managing a chronic condition, or oxytocin provided to a pregnant mother during a critical stage of care, every product must retain its efficacy throughout its journey. Achieving this requires maintaining strict temperature compliance at every touchpoint across the supply chain.
Therefore, our mission is to preserve the integrity of these biological products within the prescribed 2°C to 8°C temperature range, from the moment they leave the manufacturing facility until the moment healthcare professionals administer them. By combining advanced refrigeration technologies, intelligent monitoring systems, and end-to-end accountability, we aim to eliminate preventable losses and strengthen trust in healthcare delivery.
That is the vision that drives us at Blackfrog Technologies: a future where every life-saving medicine, vaccine, and biological product reaches every patient, everywhere, with its safety, potency, and effectiveness fully preserved.
